Chronic kidney disease affects more than 850 million people worldwide and continues to impose a heavy clinical and economic ...
Opus Genetics, Inc. (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with ...
6don MSN
Human traits beyond inherited genes can still leave a measurable imprint on your life, study shows
Our parents' genes, even the ones we didn't inherit, leave a measurable lasting imprint on our lives. An international team ...
Opus Genetics (IRD) rated Hold: valuation hinges on AAV gene therapy success. Track LCA5 Phase 3, 2026 data catalysts & ...
While Opus Genetics, Inc. (NASDAQ:IRD) has gained 100.50% year-to-date, analysts continue to see 148.10% upside, helping it ...
Almost 50 more genes have been flagged as being linked to Alzheimer’s, along with changes in activity in crucial cells that ...
Ross Muken to assume the role of Chief Executive Officer effective July 1, 2026; Co-founder Dr. Jurgi Camblong nominated for ...
View SOPHiA GENETICS SA SOPH stock quote prices, financial information, real-time forecasts, and company news from CNN.
An individual’s genetics and their environment both shape their personality. However, opinions differ on the degree to which each of these factors influences personality, and how they contribute to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results